| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans Proteins | 51 | 2024 | 882 | 7.350 |
Why?
|
| Caenorhabditis elegans | 62 | 2024 | 1474 | 6.630 |
Why?
|
| Longevity | 22 | 2024 | 1083 | 3.550 |
Why?
|
| DNA-Binding Proteins | 38 | 2021 | 9612 | 2.160 |
Why?
|
| Transcription Factors | 41 | 2021 | 12158 | 2.050 |
Why?
|
| Germ Cells | 9 | 2015 | 644 | 1.300 |
Why?
|
| Transcription, Genetic | 22 | 2013 | 7611 | 1.190 |
Why?
|
| Unfolded Protein Response | 4 | 2018 | 239 | 1.030 |
Why?
|
| NF-E2-Related Factor 2 | 6 | 2017 | 382 | 1.000 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2024 | 2061 | 0.990 |
Why?
|
| Caloric Restriction | 2 | 2019 | 302 | 0.930 |
Why?
|
| Immediate-Early Proteins | 6 | 2014 | 444 | 0.920 |
Why?
|
| Oxidative Stress | 14 | 2018 | 3139 | 0.900 |
Why?
|
| Helminth Proteins | 7 | 2005 | 173 | 0.880 |
Why?
|
| RNA Nucleotidyltransferases | 5 | 2009 | 59 | 0.830 |
Why?
|
| Pulmonary Fibrosis | 4 | 2018 | 505 | 0.740 |
Why?
|
| Stress, Physiological | 6 | 2016 | 1407 | 0.680 |
Why?
|
| NF-E2-Related Factor 1 | 3 | 2022 | 21 | 0.640 |
Why?
|
| Gene Expression Regulation | 23 | 2017 | 11923 | 0.630 |
Why?
|
| Signal Transduction | 25 | 2024 | 23621 | 0.620 |
Why?
|
| Cysteine | 3 | 2021 | 896 | 0.600 |
Why?
|
| Transcription Factor TFIID | 3 | 2004 | 150 | 0.600 |
Why?
|
| Animals | 111 | 2024 | 168965 | 0.570 |
Why?
|
| Pulmonary Alveoli | 3 | 2018 | 665 | 0.560 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2019 | 1939 | 0.550 |
Why?
|
| RNA Interference | 13 | 2016 | 2829 | 0.530 |
Why?
|
| Aging | 8 | 2019 | 8729 | 0.520 |
Why?
|
| Multiprotein Complexes | 3 | 2024 | 1110 | 0.510 |
Why?
|
| Endoribonucleases | 2 | 2018 | 231 | 0.500 |
Why?
|
| Immunity, Innate | 5 | 2021 | 3076 | 0.500 |
Why?
|
| TATA-Binding Protein Associated Factors | 3 | 2004 | 103 | 0.430 |
Why?
|
| Oogenesis | 3 | 2008 | 125 | 0.430 |
Why?
|
| RNA, Messenger | 7 | 2024 | 12793 | 0.420 |
Why?
|
| Oocytes | 3 | 2006 | 1168 | 0.400 |
Why?
|
| RNA, Helminth | 3 | 2009 | 60 | 0.400 |
Why?
|
| Embryo, Nonmammalian | 6 | 2013 | 910 | 0.390 |
Why?
|
| Antioxidants | 4 | 2021 | 1671 | 0.380 |
Why?
|
| Sirtuins | 1 | 2014 | 322 | 0.380 |
Why?
|
| Endoplasmic Reticulum | 4 | 2018 | 1132 | 0.380 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2011 | 31 | 0.380 |
Why?
|
| Gene Silencing | 3 | 2008 | 1505 | 0.370 |
Why?
|
| Macrophages, Alveolar | 3 | 2014 | 413 | 0.370 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2021 | 694 | 0.370 |
Why?
|
| Forkhead Transcription Factors | 6 | 2019 | 1626 | 0.360 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2022 | 1319 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2014 | 3610 | 0.360 |
Why?
|
| DNA | 13 | 2003 | 7210 | 0.360 |
Why?
|
| NAD | 1 | 2014 | 618 | 0.350 |
Why?
|
| Molecular Sequence Data | 30 | 2005 | 17608 | 0.340 |
Why?
|
| Apoptosis | 7 | 2018 | 9513 | 0.340 |
Why?
|
| Sirolimus | 2 | 2019 | 1539 | 0.340 |
Why?
|
| RNA-Binding Proteins | 4 | 2005 | 1889 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2014 | 998 | 0.320 |
Why?
|
| RNA, Messenger, Stored | 1 | 2008 | 5 | 0.320 |
Why?
|
| Cytoplasm | 3 | 2016 | 1504 | 0.320 |
Why?
|
| Metformin | 1 | 2016 | 908 | 0.320 |
Why?
|
| Insulin | 5 | 2019 | 6602 | 0.320 |
Why?
|
| Cytoplasmic Structures | 1 | 2008 | 21 | 0.310 |
Why?
|
| Polysomnography | 7 | 2016 | 1868 | 0.310 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2008 | 30 | 0.310 |
Why?
|
| Endoderm | 2 | 2013 | 165 | 0.300 |
Why?
|
| Phosphorylation | 12 | 2014 | 8310 | 0.300 |
Why?
|
| RNA Polymerase II | 6 | 2006 | 549 | 0.290 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2004 | 1836 | 0.290 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 1895 | 0.290 |
Why?
|
| Meiosis | 2 | 2008 | 326 | 0.280 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2019 | 414 | 0.280 |
Why?
|
| Collagen | 2 | 2014 | 2636 | 0.270 |
Why?
|
| Amino Acid Sequence | 18 | 2013 | 13411 | 0.270 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2024 | 103 | 0.270 |
Why?
|
| Cytoplasmic Granules | 3 | 2009 | 574 | 0.270 |
Why?
|
| Herpesviridae Infections | 1 | 2008 | 268 | 0.270 |
Why?
|
| Ubiquitin | 1 | 2011 | 842 | 0.260 |
Why?
|
| Mitochondria | 7 | 2021 | 3678 | 0.260 |
Why?
|
| Immunoglobulin Variable Region | 10 | 1991 | 419 | 0.260 |
Why?
|
| Mesoderm | 2 | 2013 | 679 | 0.260 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 2093 | 0.260 |
Why?
|
| MyoD Protein | 6 | 2000 | 143 | 0.250 |
Why?
|
| Conserved Sequence | 3 | 2006 | 1160 | 0.250 |
Why?
|
| Lipopolysaccharides | 6 | 2017 | 2217 | 0.250 |
Why?
|
| Muscle Strength | 1 | 2009 | 640 | 0.240 |
Why?
|
| Osteoporosis | 5 | 2010 | 1604 | 0.240 |
Why?
|
| I-kappa B Kinase | 3 | 2014 | 250 | 0.240 |
Why?
|
| Drosophila Proteins | 4 | 2019 | 1705 | 0.240 |
Why?
|
| Clodronic Acid | 1 | 2004 | 60 | 0.240 |
Why?
|
| Movement | 2 | 2015 | 1473 | 0.230 |
Why?
|
| NF-kappa B | 4 | 2013 | 2493 | 0.230 |
Why?
|
| Leucine Zippers | 3 | 2000 | 116 | 0.230 |
Why?
|
| Binding Sites | 16 | 2013 | 6014 | 0.220 |
Why?
|
| Zinc Fingers | 3 | 2002 | 577 | 0.220 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 5794 | 0.220 |
Why?
|
| Salix | 1 | 2012 | 3 | 0.210 |
Why?
|
| Geriatric Assessment | 3 | 2009 | 1422 | 0.210 |
Why?
|
| Cognition Disorders | 6 | 2009 | 3968 | 0.210 |
Why?
|
| Electrophysiology | 1 | 2005 | 1263 | 0.210 |
Why?
|
| Aspartic Acid Proteases | 1 | 2022 | 9 | 0.200 |
Why?
|
| Repressor Proteins | 4 | 2012 | 2979 | 0.200 |
Why?
|
| Transcriptional Activation | 3 | 2006 | 1751 | 0.200 |
Why?
|
| Transcription Factors, TFII | 1 | 2001 | 62 | 0.190 |
Why?
|
| Base Sequence | 22 | 2013 | 12414 | 0.190 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2022 | 86 | 0.190 |
Why?
|
| Nocturnal Myoclonus Syndrome | 2 | 2015 | 52 | 0.190 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2021 | 54 | 0.190 |
Why?
|
| Genes, Immunoglobulin | 7 | 1994 | 283 | 0.180 |
Why?
|
| Transfection | 7 | 2016 | 5753 | 0.180 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2002 | 169 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2002 | 209 | 0.180 |
Why?
|
| Cell Nucleus | 6 | 2017 | 2875 | 0.180 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 367 | 0.180 |
Why?
|
| RNA Helicases | 1 | 2001 | 144 | 0.180 |
Why?
|
| Hydrogen Sulfide | 1 | 2022 | 148 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2016 | 432 | 0.170 |
Why?
|
| Reactive Oxygen Species | 5 | 2017 | 2144 | 0.170 |
Why?
|
| MicroRNAs | 5 | 2016 | 3792 | 0.170 |
Why?
|
| Plant Extracts | 2 | 2012 | 496 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2024 | 903 | 0.170 |
Why?
|
| Tristetraprolin | 5 | 2004 | 40 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4349 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2003 | 661 | 0.170 |
Why?
|
| Receptor, Insulin | 2 | 2017 | 839 | 0.170 |
Why?
|
| Fractures, Bone | 3 | 2007 | 2062 | 0.160 |
Why?
|
| Models, Biological | 9 | 2021 | 9464 | 0.160 |
Why?
|
| Alternative Splicing | 1 | 2024 | 1103 | 0.160 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1989 | 18 | 0.160 |
Why?
|
| Activating Transcription Factors | 1 | 2019 | 30 | 0.160 |
Why?
|
| Drosophila | 3 | 2019 | 1509 | 0.160 |
Why?
|
| Cell Survival | 4 | 2008 | 5750 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2004 | 3738 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4925 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4572 | 0.150 |
Why?
|
| Transcription Factor CHOP | 1 | 2018 | 69 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 724 | 0.150 |
Why?
|
| Mice | 39 | 2018 | 81912 | 0.150 |
Why?
|
| Fungal Proteins | 1 | 2002 | 901 | 0.150 |
Why?
|
| Models, Molecular | 3 | 2003 | 5388 | 0.150 |
Why?
|
| Leg | 2 | 2015 | 1087 | 0.140 |
Why?
|
| Nonheme Iron Proteins | 1 | 2017 | 9 | 0.140 |
Why?
|
| RNA | 5 | 2004 | 2715 | 0.140 |
Why?
|
| Triclosan | 1 | 2017 | 59 | 0.140 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 1990 | 549 | 0.140 |
Why?
|
| Pyrimidinones | 1 | 2019 | 385 | 0.140 |
Why?
|
| Inflammation | 5 | 2014 | 10869 | 0.140 |
Why?
|
| Homeodomain Proteins | 3 | 2015 | 2429 | 0.140 |
Why?
|
| Lithium | 1 | 2019 | 600 | 0.130 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Protein Subunits | 3 | 2004 | 940 | 0.130 |
Why?
|
| Lipogenesis | 1 | 2017 | 217 | 0.130 |
Why?
|
| Recombination, Genetic | 6 | 1989 | 1524 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 215 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 378 | 0.120 |
Why?
|
| Pneumonia | 3 | 2017 | 2159 | 0.120 |
Why?
|
| Protein Binding | 8 | 2013 | 9327 | 0.120 |
Why?
|
| Humans | 59 | 2024 | 767040 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 393 | 0.120 |
Why?
|
| Cell Polarity | 1 | 2018 | 637 | 0.120 |
Why?
|
| Oxidoreductases | 1 | 2017 | 409 | 0.120 |
Why?
|
| Sleep Deprivation | 2 | 2014 | 848 | 0.110 |
Why?
|
| RNA Stability | 2 | 2008 | 319 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 4 | 2000 | 899 | 0.110 |
Why?
|
| B-Lymphocytes | 13 | 1994 | 4787 | 0.110 |
Why?
|
| Muscle Proteins | 4 | 1993 | 1160 | 0.110 |
Why?
|
| Pyridones | 1 | 2019 | 819 | 0.110 |
Why?
|
| 14-3-3 Proteins | 3 | 2006 | 221 | 0.110 |
Why?
|
| Animals, Genetically Modified | 4 | 2022 | 1562 | 0.110 |
Why?
|
| DNA Primers | 4 | 2014 | 2827 | 0.110 |
Why?
|
| Lung | 5 | 2013 | 10076 | 0.110 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 30 | 0.110 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2013 | 31 | 0.110 |
Why?
|
| Prostaglandin D2 | 1 | 2013 | 108 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 1 | 2014 | 244 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 105 | 0.110 |
Why?
|
| Mutation | 11 | 2021 | 30211 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 4 | 2004 | 2628 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 754 | 0.100 |
Why?
|
| Larva | 1 | 2014 | 512 | 0.100 |
Why?
|
| Structure-Activity Relationship | 4 | 2002 | 3052 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2017 | 1008 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2007 | 399 | 0.100 |
Why?
|
| Protein Folding | 3 | 2008 | 869 | 0.100 |
Why?
|
| Lipocalins | 1 | 2013 | 160 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2416 | 0.100 |
Why?
|
| Hot Flashes | 2 | 2007 | 330 | 0.100 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 521 | 0.100 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 1990 | 89 | 0.100 |
Why?
|
| Restless Legs Syndrome | 1 | 2015 | 235 | 0.100 |
Why?
|
| Trans-Activators | 4 | 2012 | 2856 | 0.100 |
Why?
|
| Eating | 1 | 2019 | 1541 | 0.100 |
Why?
|
| Lung Injury | 2 | 2007 | 432 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2006 | 1647 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 252 | 0.100 |
Why?
|
| Sarcoma, Synovial | 1 | 2013 | 156 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2007 | 385 | 0.100 |
Why?
|
| Arsenites | 2 | 2009 | 65 | 0.100 |
Why?
|
| Response Elements | 1 | 2013 | 308 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 1168 | 0.090 |
Why?
|
| Tunica Intima | 1 | 2013 | 455 | 0.090 |
Why?
|
| Sleep | 4 | 2015 | 4816 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 5 | 2006 | 3760 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 1995 | 6067 | 0.090 |
Why?
|
| Mice, Transgenic | 8 | 2014 | 9551 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 393 | 0.090 |
Why?
|
| Cells, Cultured | 8 | 2018 | 18989 | 0.090 |
Why?
|
| 3T3 Cells | 3 | 2002 | 1081 | 0.090 |
Why?
|
| Genes, Regulator | 3 | 2004 | 373 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 2 | 1990 | 26 | 0.090 |
Why?
|
| Macromolecular Substances | 6 | 2004 | 1430 | 0.090 |
Why?
|
| Ribonuclease III | 1 | 2012 | 271 | 0.090 |
Why?
|
| Models, Genetic | 5 | 2004 | 3445 | 0.090 |
Why?
|
| Mice, Mutant Strains | 4 | 1990 | 1751 | 0.090 |
Why?
|
| Liver | 3 | 2009 | 7578 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2016 | 982 | 0.090 |
Why?
|
| Activity Cycles | 1 | 2010 | 47 | 0.090 |
Why?
|
| Genes, Reporter | 3 | 2004 | 1526 | 0.080 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2009 | 11 | 0.080 |
Why?
|
| Sequence Alignment | 4 | 2004 | 2176 | 0.080 |
Why?
|
| DNA, Helminth | 1 | 2009 | 36 | 0.080 |
Why?
|
| Fractures, Spontaneous | 2 | 2010 | 232 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 8 | 1990 | 647 | 0.080 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 1994 | 153 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4522 | 0.080 |
Why?
|
| Peroxiredoxins | 1 | 2008 | 51 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 2063 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2015 | 1897 | 0.080 |
Why?
|
| RNA Transport | 1 | 2008 | 42 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2003 | 1677 | 0.080 |
Why?
|
| alpha-Mannosidase | 1 | 2008 | 19 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2021 | 1244 | 0.080 |
Why?
|
| Imidazoles | 2 | 2012 | 1169 | 0.080 |
Why?
|
| Intestines | 3 | 2008 | 1905 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1965 | 0.080 |
Why?
|
| RNA Caps | 1 | 2008 | 72 | 0.080 |
Why?
|
| DNA Nucleotidyltransferases | 5 | 1989 | 177 | 0.080 |
Why?
|
| Zygote | 1 | 2008 | 117 | 0.070 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2007 | 48 | 0.070 |
Why?
|
| Vasculitis | 1 | 2012 | 526 | 0.070 |
Why?
|
| Heat-Shock Response | 1 | 2008 | 179 | 0.070 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2007 | 78 | 0.070 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2006 | 24 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 5796 | 0.070 |
Why?
|
| Bleomycin | 3 | 2018 | 492 | 0.070 |
Why?
|
| Endothelial Cells | 3 | 2012 | 3582 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1733 | 0.070 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 2221 | 0.070 |
Why?
|
| Vitamin E | 1 | 2011 | 872 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 59548 | 0.070 |
Why?
|
| Genes | 3 | 1986 | 1824 | 0.070 |
Why?
|
| Proteins | 3 | 2000 | 6001 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 820 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 5 | 0.070 |
Why?
|
| Cell Differentiation | 7 | 2014 | 11657 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 3043 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2745 | 0.060 |
Why?
|
| Positive Transcriptional Elongation Factor B | 2 | 2003 | 42 | 0.060 |
Why?
|
| Aged | 19 | 2019 | 171319 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2003 | 68 | 0.060 |
Why?
|
| Aorta | 1 | 2013 | 2045 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3587 | 0.060 |
Why?
|
| Mediator Complex | 2 | 2004 | 106 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2003 | 3073 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 22361 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 2012 | 3324 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1029 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 1608 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 624 | 0.060 |
Why?
|
| Sleep Stages | 1 | 2009 | 705 | 0.060 |
Why?
|
| Asthma | 2 | 2016 | 6268 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2005 | 151 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 4 | 1991 | 289 | 0.060 |
Why?
|
| Female | 26 | 2019 | 396660 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 131 | 0.060 |
Why?
|
| Immunoglobulin D | 1 | 1984 | 55 | 0.060 |
Why?
|
| Health Surveys | 3 | 2016 | 4056 | 0.060 |
Why?
|
| Protein Structure, Secondary | 3 | 1997 | 1211 | 0.060 |
Why?
|
| TATA Box Binding Protein-Like Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 139 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 29 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 3253 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 792 | 0.060 |
Why?
|
| Plasmids | 3 | 2003 | 2268 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 297 | 0.060 |
Why?
|
| Observation | 1 | 2005 | 310 | 0.060 |
Why?
|
| Trifolium | 1 | 2003 | 3 | 0.060 |
Why?
|
| Lymphocytes | 2 | 1989 | 2605 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2008 | 994 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5186 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2800 | 0.060 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 455 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11063 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3427 | 0.050 |
Why?
|
| Paraquat | 1 | 2003 | 36 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 1989 | 1141 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2004 | 2678 | 0.050 |
Why?
|
| Histone Chaperones | 1 | 2004 | 82 | 0.050 |
Why?
|
| Rest | 1 | 2008 | 941 | 0.050 |
Why?
|
| Observer Variation | 1 | 2009 | 2616 | 0.050 |
Why?
|
| Allergens | 1 | 2011 | 1436 | 0.050 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1994 | 171 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 760 | 0.050 |
Why?
|
| Plant Bark | 1 | 2012 | 9 | 0.050 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2012 | 24 | 0.050 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 52 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3599 | 0.050 |
Why?
|
| Chromatin | 2 | 2006 | 2980 | 0.050 |
Why?
|
| Mammals | 1 | 1989 | 1135 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 358 | 0.050 |
Why?
|
| Bone Density | 2 | 2007 | 3573 | 0.050 |
Why?
|
| Benzyl Alcohols | 1 | 2012 | 33 | 0.050 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 1597 | 0.050 |
Why?
|
| Postmenopause | 3 | 2007 | 2518 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2003 | 1989 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 4405 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 9517 | 0.050 |
Why?
|
| Phylogeny | 3 | 2007 | 2840 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 99 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2000 | 97 | 0.050 |
Why?
|
| Isoflavones | 1 | 2003 | 139 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2002 | 152 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2021 | 740 | 0.050 |
Why?
|
| Muscles | 2 | 2021 | 1576 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2009 | 2931 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1458 | 0.050 |
Why?
|
| Cell Transformation, Viral | 5 | 1990 | 527 | 0.050 |
Why?
|
| Male | 19 | 2018 | 364203 | 0.050 |
Why?
|
| Gametogenesis | 1 | 2001 | 27 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1154 | 0.050 |
Why?
|
| Time Factors | 3 | 2016 | 40154 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 1492 | 0.050 |
Why?
|
| Cell Line | 7 | 2013 | 15567 | 0.050 |
Why?
|
| Fertility | 2 | 2007 | 771 | 0.050 |
Why?
|
| DNA Polymerase II | 1 | 2001 | 103 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 839 | 0.050 |
Why?
|
| Knee Joint | 1 | 2009 | 1683 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 361 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 928 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2003 | 242 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3797 | 0.040 |
Why?
|
| Liposomes | 1 | 2004 | 787 | 0.040 |
Why?
|
| Obesity | 3 | 2014 | 13085 | 0.040 |
Why?
|
| Disease Progression | 1 | 2018 | 13646 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2021 | 147 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.040 |
Why?
|
| Templates, Genetic | 2 | 1990 | 188 | 0.040 |
Why?
|
| Mice, Knockout | 5 | 2018 | 14476 | 0.040 |
Why?
|
| Disorders of Sex Development | 1 | 2001 | 129 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2008 | 1079 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 364 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6550 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2008 | 2200 | 0.040 |
Why?
|
| Glutathione | 1 | 2012 | 589 | 0.040 |
Why?
|
| Transgenes | 1 | 2003 | 1014 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20169 | 0.040 |
Why?
|
| Body Composition | 1 | 2009 | 2454 | 0.040 |
Why?
|
| Cross-Sectional Studies | 6 | 2016 | 26325 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 1752 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2008 | 7121 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2017 | 3618 | 0.040 |
Why?
|
| Thymine | 1 | 1999 | 69 | 0.040 |
Why?
|
| Hip Fractures | 1 | 2007 | 997 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 2429 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 4401 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2008 | 1107 | 0.040 |
Why?
|
| Abelson murine leukemia virus | 5 | 1990 | 41 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 1990 | 565 | 0.040 |
Why?
|
| DNA Damage | 1 | 2008 | 2469 | 0.040 |
Why?
|
| Mortality | 1 | 2010 | 2909 | 0.040 |
Why?
|
| VDJ Recombinases | 5 | 1989 | 84 | 0.040 |
Why?
|
| Phenotype | 4 | 2004 | 16718 | 0.040 |
Why?
|
| Motor Activity | 1 | 2008 | 2713 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2906 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 541 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2002 | 1759 | 0.040 |
Why?
|
| Glucosides | 1 | 2012 | 533 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2952 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 146 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2003 | 1141 | 0.040 |
Why?
|
| Vertebrates | 1 | 1999 | 227 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2014 | 13048 | 0.040 |
Why?
|
| Oligonucleotides | 2 | 1990 | 561 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3418 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1716 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2275 | 0.040 |
Why?
|
| Mental Status Schedule | 2 | 2008 | 315 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2007 | 4167 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6287 | 0.030 |
Why?
|
| Xenopus | 1 | 1999 | 710 | 0.030 |
Why?
|
| Alleles | 4 | 2015 | 6893 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1540 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1621 | 0.030 |
Why?
|
| Diet | 1 | 2014 | 8089 | 0.030 |
Why?
|
| Garlic | 1 | 2016 | 28 | 0.030 |
Why?
|
| Cloning, Molecular | 5 | 2003 | 4167 | 0.030 |
Why?
|
| Feedback | 1 | 2000 | 797 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 1999 | 435 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2014 | 818 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2006 | 2116 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 661 | 0.030 |
Why?
|
| Rabbits | 1 | 2002 | 4751 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16036 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1676 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2005 | 1389 | 0.030 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1995 | 20 | 0.030 |
Why?
|
| G-Box Binding Factors | 1 | 1994 | 8 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2014 | 2677 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1995 | 100 | 0.030 |
Why?
|
| Menopause | 1 | 2003 | 1655 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1995 | 226 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1494 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2003 | 2575 | 0.030 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1994 | 62 | 0.030 |
Why?
|
| Endocrine Disruptors | 1 | 2017 | 265 | 0.030 |
Why?
|
| Oncogenes | 1 | 2000 | 1232 | 0.030 |
Why?
|
| Autoradiography | 1 | 1995 | 725 | 0.030 |
Why?
|
| Pyrvinium Compounds | 1 | 2013 | 3 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 2012 | 0.030 |
Why?
|
| Risk Factors | 6 | 2015 | 74886 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 2013 | 116 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2015 | 41718 | 0.030 |
Why?
|
| Adenine | 1 | 1999 | 995 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 2086 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2013 | 224 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 1995 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2021 | 1865 | 0.030 |
Why?
|
| Spirometry | 1 | 2016 | 928 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 134 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1990 | 3948 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 980 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 1986 | 853 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2012 | 42 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3726 | 0.020 |
Why?
|
| Starvation | 1 | 2012 | 141 | 0.020 |
Why?
|
| Gravitation | 1 | 2012 | 82 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
| Leukocytes | 2 | 2012 | 2034 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2014 | 5022 | 0.020 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 64 | 0.020 |
Why?
|
| Genes, myc | 1 | 1993 | 391 | 0.020 |
Why?
|
| Macrophages | 3 | 2013 | 5785 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 874 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6507 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2014 | 554 | 0.020 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1990 | 24 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 751 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 597 | 0.020 |
Why?
|
| Pyridines | 1 | 2012 | 2890 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2016 | 9660 | 0.020 |
Why?
|
| Endotoxemia | 1 | 2012 | 198 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 414 | 0.020 |
Why?
|
| Disulfides | 1 | 1992 | 462 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 1990 | 138 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1993 | 326 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1376 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 804 | 0.020 |
Why?
|
| Dementia | 1 | 2005 | 2741 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2003 | 3446 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5141 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 94 | 0.020 |
Why?
|
| E-Selectin | 1 | 2012 | 576 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 588 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10748 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1997 | 3684 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2017 | 1806 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2012 | 186 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 692 | 0.020 |
Why?
|
| Serine | 2 | 2004 | 828 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5693 | 0.020 |
Why?
|
| Prevalence | 3 | 2016 | 15851 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1864 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 2415 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 792 | 0.020 |
Why?
|
| Antibodies | 2 | 1987 | 2419 | 0.020 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 52 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1990 | 2568 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1989 | 110 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 781 | 0.020 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 15925 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18330 | 0.020 |
Why?
|
| Cholesterol | 1 | 2017 | 2905 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 377 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1996 | 1366 | 0.020 |
Why?
|
| Spinal Fractures | 2 | 2005 | 710 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2015 | 3621 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4280 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2870 | 0.020 |
Why?
|
| Antibody Diversity | 1 | 1987 | 72 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 520 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1459 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39317 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22350 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2001 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 1873 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1984 | 548 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2007 | 197 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3913 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5891 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1758 | 0.020 |
Why?
|
| Electrooculography | 1 | 2006 | 112 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4780 | 0.020 |
Why?
|
| Peptides | 2 | 2003 | 4348 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1665 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 1075 | 0.020 |
Why?
|
| United States | 5 | 2016 | 72971 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2007 | 260 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 252 | 0.020 |
Why?
|
| Actigraphy | 1 | 2010 | 527 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 996 | 0.020 |
Why?
|
| Snoring | 1 | 2007 | 211 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2009 | 593 | 0.020 |
Why?
|
| Fetus | 1 | 2013 | 1878 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 757 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2007 | 336 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6215 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 1646 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4114 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1384 | 0.010 |
Why?
|
| Immunoglobulin Fragments | 1 | 1984 | 83 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2014 | 1942 | 0.010 |
Why?
|
| Uridine | 1 | 2004 | 135 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1984 | 310 | 0.010 |
Why?
|
| Rats | 2 | 2006 | 23713 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1984 | 286 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2012 | 1811 | 0.010 |
Why?
|
| Phytoestrogens | 1 | 2003 | 59 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2009 | 811 | 0.010 |
Why?
|
| California | 1 | 2007 | 1439 | 0.010 |
Why?
|
| Plant Preparations | 1 | 2003 | 94 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1757 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 30238 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 1966 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 251 | 0.010 |
Why?
|
| Adipocytes | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2003 | 266 | 0.010 |
Why?
|
| Histidine | 1 | 2003 | 301 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 2591 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2003 | 556 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2014 | 54886 | 0.010 |
Why?
|
| Comorbidity | 2 | 2008 | 10582 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3227 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 14766 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13284 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1135 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2003 | 472 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1218 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1677 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1405 | 0.010 |
Why?
|
| Neutrophils | 1 | 2013 | 3779 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1660 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1419 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1984 | 805 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 613 | 0.010 |
Why?
|
| Cell Movement | 1 | 2012 | 5203 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6513 | 0.010 |
Why?
|
| Critical Illness | 1 | 2012 | 2753 | 0.010 |
Why?
|
| Cause of Death | 1 | 2010 | 3717 | 0.010 |
Why?
|
| Adenosine | 1 | 2004 | 812 | 0.010 |
Why?
|
| Middle Aged | 5 | 2019 | 223233 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3060 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2478 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6331 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1893 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1984 | 2843 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22254 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1550 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8628 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 1182 | 0.010 |
Why?
|
| T-Lymphocytes | 4 | 1990 | 10254 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 3229 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4968 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 17097 | 0.010 |
Why?
|
| Genes, MHC Class II | 2 | 1989 | 433 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1065 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2009 | 3986 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 573 | 0.010 |
Why?
|
| Hypertension | 1 | 2015 | 8615 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 1892 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9606 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 6023 | 0.010 |
Why?
|
| Ovary | 1 | 1999 | 965 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2887 | 0.010 |
Why?
|
| Interleukin-7 | 1 | 1994 | 146 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 661 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9362 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 861 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1992 | 155 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1992 | 333 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1996 | 1750 | 0.010 |
Why?
|
| Adult | 3 | 2013 | 223317 | 0.010 |
Why?
|
| Mice, Inbred NZB | 1 | 1991 | 57 | 0.010 |
Why?
|
| Vitamin D | 1 | 2005 | 3312 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2006 | 6282 | 0.010 |
Why?
|
| Immunoglobulin delta-Chains | 1 | 1990 | 7 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18401 | 0.010 |
Why?
|
| Hybridomas | 1 | 1991 | 442 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1990 | 58 | 0.010 |
Why?
|
| Genetic Engineering | 2 | 1986 | 935 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2448 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 848 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12451 | 0.000 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1989 | 111 | 0.000 |
Why?
|
| Gene Expression | 2 | 1994 | 7587 | 0.000 |
Why?
|
| Multigene Family | 1 | 1991 | 1081 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3440 | 0.000 |
Why?
|
| Incidence | 1 | 2005 | 21526 | 0.000 |
Why?
|
| Depression | 1 | 2006 | 8234 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 59980 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1994 | 2412 | 0.000 |
Why?
|
| Genetic Code | 1 | 1986 | 139 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 89046 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1986 | 209 | 0.000 |
Why?
|
| Plasmacytoma | 1 | 1984 | 170 | 0.000 |
Why?
|
| Immune System Diseases | 1 | 1986 | 253 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8717 | 0.000 |
Why?
|
| Kidney | 1 | 1999 | 7063 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 24299 | 0.000 |
Why?
|
| Quality of Life | 1 | 2003 | 13485 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1992 | 4209 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 81659 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2005 | 65295 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1990 | 3408 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1986 | 4616 | 0.000 |
Why?
|
| Lymphoma | 1 | 1984 | 1896 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1984 | 2926 | 0.000 |
Why?
|